Serotiny designs novel multi-domain proteins for enhanced control of cell and gene therapies.
Location: United States, California, San Francisco
Employees: 11-50
Founded date: 2014
Investors 2
| Date | Name | Website |
| - | ND CAPITAL | nd.capital |
| - | MBC BioLab... | mbcbiolabs... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 06.06.2022 | Serotiny Announces a Research Collaboration With Janssen to ... | The collaboration will utilize the Serotiny platform to design, analyze, evaluate, and screen Multi-... | venturebea... |
| 28.02.2022 | Serotiny and Tessera Therapeutics enter into collaboration t... | The collaboration will utilize the Serotiny platform to engineer, analyze, score, and screen Multi-D... | venturebea... |